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Abstract  
BACKGROUND: Ziziphus jujuba belongs to family Rhamnaceae widely distributed in subtropical and tropical 
countries. It is used traditionally for several pharmacological purposes including anti-inflammation, antidiarrhoeal 
and antibacterial, as well as tonic and sometimes as hypnotic (sedative).  
AIM: To determine the in vivo antidiarrhoeal, antibacterial and anti-inflammatory activities of Z. jujuba fruit 
ethanolic extract.  
METHOD: The fruit was macerated and extracted by 95% (v/v) ethanol. The antidiarrhoeal activity was evaluated 
using castor oil and Escherichia coli induced diarrhoea mouse model. The antidiarrhoeal and antibacterial activity 
was investigated at graded doses (400-1200 mg/kg). The anti-inflammatory effects were tested using the 
carrageenan-induced paw oedema in female Wistar rats. Rat’s treatment groups received tragacanth, 100 mg/kg 
diclofenac sodium, 800 mg/kg, 1200 mg/kg or 1600 mg/kg of an ethanolic extract of Z. jujuba (EEZJ). All 
treatment groups were fed with the compounds one hour before carrageenan injection at of rat’s paw. Also, the 
EEZJ was further analysed by HPLC-PDA system for identification of the presence of betulinic acid and quercetin.  
RESULTS: EEZJ different doses did not show inhibitory activity against castor oil induced diarrhoea except for 
the higher (1200 mg/kg) dose. However, the frequency of defecation of stools and watery stool were reduced 
significantly when compared to control group (P ≤ 0.05 and P ≤ 0.01 respectively), resulted in overall 67% 
inhibition of diarrhoea. Our anti-inflammatory results demonstrated that EEZJ was able to inhibit the carrageenan-
induced paw oedema in rats to a significant degree (p ≤ 0.05) and the paw volume and thickness of both left and 
right paw were affected compared to the negative control group.  
CONCLUSION: EEZJ possesses antidiarrhoeal and antibacterial activity in a dose depending manner and may 
provide a pharmacological basis for its clinical use in diarrheal diseases. The activity may partially be due to the 
presence of betulinic acid and quercetin. 
 
 
 
 
 
 
 
 
Introduction 
 
Ziziphus jujuba Mill. (family: Rhamnaceae), is 
a thorny tree of medium height, whose fruit resembles 
buckthorn or olive fruit and had been widely 
consumed as both fruit and remedy for a long time all 
around the world. It has been listed among the first 
most valuable fruits in ancient Chinese medicine 
books. Moreover, in the Chinese herbal medicine, it is 
considered as one of the superior herbal medicines 
and thought to possess the effect of prolonging 
lifespan by purifying and nourishing blood, treating 
insomnia and help in digestion. Nowadays, Z. jujuba 
fruit is believed to be one of the nutritious foods as it 
contains plenty of nutrients which consists of amino 
acids, carbohydrates, minerals and vitamins [1] [2]. 
 Regarding the geographical distribution, Z. 
jujuba is widely found in the tropical and subtropical 
regions of Asia and America as well as in the 
Mediterranean regions [3]. It is well known in the 
Arabian Peninsula since ancient time. However, it is 
believed to be originated in the Algerian town of 
Annaba, due to which it has been named Annab. 
Furthermore, the mature fruit of Z. jujuba is red to 
purplish black, resembling small dates. Therefore in 
China are known as Chinese red date or Chinese 
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jujuba. The dried pulp of Z. jujuba is a source of 
essential unsaturated fatty acids. The main fatty acids 
in the jujube are oleic, linoleic (omega-6), palmitic, 
and palmitoleic acids. Jujube fruits contain various 
types of amino acids and proteins. The protein and 
free asparagines content are influenced and 
accumulated potentially during the ripening and 
harvesting stage
 
[4]. 
Dietary fibre and fructose contents of the 
jujube fruit play a role in the regulation of blood sugar 
levels by slowing digestion
 
[5]. The major sugars 
found in the jujube fruit are glucose, fructose, sucrose, 
rhamnose and sorbitol. The fruit is also abundant in 
vitamin C, which is one of the water-soluble 
antioxidants
 
[6]. The postharvest sorting process is 
important for increasing the economic benefits and 
dietary values of the jujube fruit, especially vitamin C 
content protection during storage and marketing
 
[7]. 
Moreover, the jujube is enriched, nevertheless to a 
lesser extent, with other vitamins including thiamin, 
riboflavin, niacin, vitamin B6, and vitamin A. Jujube 
fruit is also considered a good source of minerals 
such as magnesium, phosphorus, potassium, sodium, 
and zinc
 
[6]. Various studies have shown that the 
jujube fruit contains many bioactive compounds, 
including triterpenic acids, flavonoids, cerebrosides, 
phenolic acids, α-tocopherol, β-carotene, and 
polysaccharides. Each constituent of the jujube 
presents some health benefits, thus making it a 
healthy food choice
 
[8]. The total phenolic compounds 
in jujube fruit which is accounted for the antioxidant 
activities are higher compared to other common fruits, 
such as cherry, apple, persimmon, or red grape
 
[9]. 
Flavonoids, phenolic acids, tannins, stilbenes, and 
lignans are derivatives of phenolic compounds [10] 
[11] [12]. 
The Indian jujuba, Ziziphus mauritiana Lam. 
and Z. jujuba Mill. Are the two main domesticated 
jujubes. The pantropical genus Ziziphus Mill. Includes 
approximately 170 species with a few species 
occurring in temperate regions. Recent studies on the 
biological activities of this fruit have supported the 
health benefits of jujube as both food and medicinal 
herb. Different parts of Z. jujuba are used traditionally 
for curing many kinds of illness including diabetes, 
diarrhoea, liver complaints, urinary disorders, obesity, 
skin infections, respiratory infections, anaemia, 
insomnia, cancer, and also for blood purification and 
modification of the gastrointestinal tract [ [6] 13] [14]. 
Z. jujuba is used traditionally as a tonic and 
sometimes as hypnotic-sedative. Additionally, there 
are studies that had been carried out to test its 
anxiolytic, anticancer, antimicrobial, anti-inflammatory, 
anti-allergy, cognitive, anti-nephritic, antioxidant and 
wound healing properties
 
[8] [15]. 
The anxiolytic effect in vivo had been reported 
in a polyherbal substance which consists of seed 
extract of Z. jujuba
 
[16]. The possibility of improving 
cytotoxic activity was suggested to be due to the 
presence of coumaroyl moiety at the carbon-3 position 
of the lupanetype triterpene, extracted from Z. jujuba 
[17]. Selective toxicity against cultured human 
melanoma cells is also performed by the triterpenes 
acid and betulinic acid extracted from Z. jujuba and 
Ziziphus mauritiana
 
[18]. Notable inhibitory activity 
performed by ethanolic extract of Z. jujuba root on 
fungi Candida albicans, C. tropicalis, Aspergillus 
flavus and A. niger showed convincing antifungal 
activity
 
[19]. Additionally, extract of root bark of Z. 
jujuba exhibited antibacterial activity against 20 
bacteria
 
[20].  
A traditional Chinese prescription, Huangqin 
Tang with fruit content from Z. jujuba had shown 
remarkable anti-inflammatory and antispasmodic 
effect
 
[21]. Additionally, Ziziphus mauritiana leaf 
extracts were also found to possess significant anti-
inflammatory activity against carrageenan induced rat 
paw oedema
 
[22]. The anti-allergic activity of the 
aqueous extracts of leaves of Z. jujuba was studied by 
measuring its inhibitory effect on hyaluronidase or 
bovine testes activation in vitro. Z. jujuba was shown 
to have strong antiallergic and anti-anaphylactic 
activity
 
[23] [24]. A component of Z. jujuba extract, 
oleamide poses possible potential against Alzheimer's 
disease as it could be a useful chemopreventative 
agent
 
[25] [26]. Methanolic extract of Z. jujuba was 
found to show activation effect on choline 
acetyltransferase in vitro as high as 34.1%. 
Moreover, Z. jujuba also exhibits possibly 
anti-nephritic effect by increasing renal blood flow and 
thus reducing inflammation of kidney
 
[27]. Two reports 
studied 70 antioxidant Korean medicinal plants listed 
the in vitro antioxidant effect of Z. jujuba
 
[28] [29]. The 
wounding healing effect had been reported on the 
extract of Z. jujuba root
 
[30]. Furthermore, a rat model 
which uses an ointment formula at a dose 0.5% and 
1% on topical application proved the wound healing 
activity of the extract of Z. jujuba root
 
[31]. The main 
aim of the current studies was to further explore the 
anti-inflammatory and anti-diarrhoeal activities of 
ethanolic extract of Ziziphus jujube fruit. 
 
 
Materials and Methods 
 
The 1 ml and 10 ml disposable syringes, 
amber bottles, oral gavage and 27G needle, were 
purchased from Terumo Tokyo–Japan. Digital 
Plethysmometer (model 7140, Ugo Basile, Italy), 
weighing balance (A & D, Tokyo, Japan), freezer 
(Action International, Kuala Lumpur, Malaysia), 
refrigerator (Sharp Malaysia), cell culture incubator 
(CL-170B-8, ESCO, Singapore), rotary evaporator 
(Butchi Rotavapour model R-114, Büchi Labortechnik 
AG, Flawil Switzerland). The plastic cages, water 
bottles, white cloth, tissue paper, masks, gloves, 
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vacuum pump and vortex, were from Autovortex SA6, 
Stuart Scientific, UK. HPLC machine (Waters 2695; 
WATERS CORPORATION, Milford, MA 01757 USA), 
Ultra-purified water machine (ELGA Labwater 
Purification System, High Wycombe HP14 3BY, UK). 
The dried granules of fruits (2744.58 g) were 
extracted by cold maceration for 72 hours with 95% of 
ethanol. The solutions were filtered using vacuum 
filtration. The filtrates were then concentrated in a 
rotary evaporator to eliminate ethanol and yielded 
semi-solid extract. Immersion, filtration and rotary 
evaporation process were repeated for three times. 
The extract of Z. jujuba was preserved at 10
o
C until 
further use
 
[24]. 
Different concentration of EEZJ, loperamide, 
and diclofenac sodium salt were freshly prepared in 
tragacanth compound powder suspension prior 
administration. Carrageenan powder was added into 
normal saline to create 1% w/v carrageenan solution 
at 4
o
C and stirred immediately. Any remaining lumps 
were dispersed by using vortex. The solution was 
warmed to 50
o
C with stirring. After that, the solution 
was incubated at 40
o
C for less than 24 hours before 
use [32]. 
Sample (EEZJ) and standards (betulinic acid 
and quercetin) were weighed and transferred into 
three 2 ml vials, respectively. After dissolved in 100% 
methanol, solutions were filtered through 0.45 µm 
membrane filters before HPLC analysis, Guo et al.
 
[33]. 
The bacterial inoculum suspension of E. coli 
(ATCC 25927) was prepared by direct transfer of 
bacteria from stock culture into nutrient broth 
contained in the universal bottle. Few loops of stock 
culture were transferred into the sterile nutrient broth 
and incubated for 24 hours at 37
o
C prior 
administration. E. coli suspension was then compared 
with McFarland standards to obtain the desired 
turbidity of bacterial suspension. The minimum 
effective dose obtained from this test will determine 
the doses of choice in the in vivo antidiarrhoeal 
experiment and in vivo antibacterial experiment [33].  
Following Sahoo et al. work [34] the 
preliminary in vivo assay using mice, six mice were 
separated randomly into two groups of three animals 
each. The turbidity of E. coli inoculum suspensions 
was adjusted to McFarland Standard No. 1 (3.0x10
8
 
CFU /ml), No. 2 (6.0x10
8
 CFU/ml) prior administration 
to mice. Group 1 received 1 ml of E. coli inoculum 
suspension of McFarland Standard No.1 while group 
2 received 1 ml of E. coli inoculum suspension of 
McFarland Standard No.2. Following treatment of E. 
coli suspension, mice were placed and observed for 
subsequence eight hours in the separated beaker 
which consists of white filter paper. The filter paper 
was changed hourly. Several parameters such as the 
weight of stools, the frequency of total stools and 
watery stools were taken for measuring purpose. After 
eight hours of observation, mice were sacrificed, and 
the intestines were removed. Any abnormalities such 
as ulceration, perforation and redness were observed 
and recorded. The minimum concentration of E. coli 
that induced abnormalities in intestines of the mice 
was used in the antibacterial activity experiment. 
Base on experiment used by Ayalate and his 
colleagues [36], thirty mice with a weight of 20-35 g 
were separated into six groups of five animals each. 
All five groups of animals were fed orally with 1 ml of 
E. coli suspension using gavage needle with turbidity 
similar to McFarland Standard No. 1 three hours prior 
administration of suspension. Group 1 received 0.2 ml 
of tragacanth 2% orally and served as the control 
group while group 2 received antibiotic (Amoxicillin 
260 mg/kg) and served as positive control. Group 3, 4 
and 5 received 400 mg/kg, 800 mg/kg and 1200 
mg/kg of EEZJ, respectively. Following treatment with 
drug and extraction suspension, mice were separated 
and placed individually into a different beaker 
containing a white filter paper and observed for the 
subsequent four hours. The white filter papers were 
changed hourly.  
 RA was calculated according to the following 
formula:  
Total mucosal area
Relative area = 
Total ulcerated area
 
Meanwhile, approximately 2000 mg of stools 
of each mouse were collected and suspended into 5 
ml of sterile phosphate-buffered saline (PBS) to 
produce suspension A, which underwent vigorous 
shaking by a vortex mixer for at least 15 minutes. 
Then, 100 µl of the suspension A was diluted into 10 
ml of sterile PBS to form suspension B. Afterwards, 
100 µL of the suspension B was spread on to the 
MacConkey agar plates and incubated at 37
o
C for 24 
hours. Later the growth of bacterial colony was 
observed and counted by using colony counter.  
A preliminary study was carried out to 
determine the dose of carrageenan to induce paw 
oedema in rats. Moreover, the effective doses of plant 
extract that exert an observable anti-diarrhoeal effect 
on castor oil induced diarrhoea, as well as anti-
inflammatory effects on carrageenan-induced paw 
oedema were determined in the current study.  
Following Wang et al.
 
method
 
[33], 30 mice 
were selected and divided randomly into six groups of 
five animals each. The weight of all mice was in the 
range of 20-35 g. Group 1 and group 2 were 
administered with 0.2 ml of 2% tragacanth and 4.2 
mg/kg loperamide HCl respectively. Group 3, 4 and 5 
received 400 mg/kg, 800 mg/kg and 1200 mg/kg of 
EEZJ, respectively. Mice acute diarrhoea was induced 
with 0.2 ml of castor oil one hour after administration 
of oral suspension. After the supply of castor oil, 
animals were placed in the separated beakers which 
consist of white filter paper. The filter papers were 
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changed every hour for subsequence four hours. Mice 
were under direct observation for the onset of 
diarrhoea, weight of stools, and frequency of total 
stools and watery stools during the four hours. The 
proportion of the weight of watery stools was 
calculated based the formula that developed by Wang 
et al.,
 
[33].  
Weight of watery stool
Proportion of weight of watery stool = 100
Total weight of stool

 
The percentage of inhibition of defaecation 
and diarrhoea were calculated according to the 
formula that developed by Lumpu et al., [37].  
Pc - Ps
Percentage inhibition of defaecation = 100
Pc

 
Where Pc is the average number of 
defecation of control group while Ps is the average 
number of defaecation of the test group.  
Dc - Ds
Percentage inhibition of diarrhoea = 100
Dc

 
Where Dc is the average number of diarrhoea 
of control group, while Ds is the average number of 
diarrhoea of test group.  
Acute inflammation was induced by 
subplantar injection of 0.1 ml carrageenan solution 
(1% w/v in normal saline) in the hind paw of each rat. 
Before injection, the rat paw was held still and steady 
to ensure the injection site was cleared and 
observable. Different groups of rats were administered 
either solution of Z. jujuba ethanolic extract (800 
mg/kg, 1200 mg/kg or 1600 mg/kg), diclofenac sodium 
(100 mg/kg) or negative control solution (2% 
tragacanth) orally, one hour before carrageenan 
injection. The paw volume and thickness were 
measured by plethysmometer and digital calliper 
respectively immediately before carrageenan injection 
(0 h) and the consecutive six hours with the one-hour 
interval between two readings
 
[38]. 
Paw volume was measured by dipping the rat 
paw into the tube until marked level, and the pedal 
switch was pressed to get the data value after the 
figure stabilised. The rat feet were kept still and 
steady during measurement process to improve 
accuracy and consistency. Every time after data value 
was taken, the meter was zeroed before next 
measurement. The thickness of the paw was taken at 
the marked line to ensure the consistency and 
accuracy of the data value by using a digital calliper.  
The extent of inflammation was expressed as 
percent (%) oedema and calculated as below
 
[39]: 
 % oedema =    
Where α and β are the paw volume/ thickness 
after carrageenan injection and paw volume/ 
thickness before carrageenan injection respectively. 
The anti-inflammatory effects were deduced from the 
extent of inflammation. The greater the extent of 
inflammation, the less anti-inflammatory effects 
exerted by that treatment group. 
HPLC analysis was performed on a Waters 
2695 Alliance HPLC system (Waters Corporation, 
United States of America), equipped with a quaternary 
pump solvent management system, an auto-sampler, 
and an on-line degasser. The separation was carried 
out with an XBridge™ C18 column (4.6 mm x 250 
mm) while raw data were detected by Waters 2998 
PDA and processed with EmpowerTM Software. The 
column temperature was 25◦C.  
The mobile phase for betulinic acid HPLC 
qualification was composed of A (acetonitrile) and B 
(0.1 % acetic acid) at the flow rate of 1.0 ml/min. The 
elution concentration of mobile phase were: 0-5 min 
(A: 20%; B: 80%), 6-25 min (A: 70%; B: 30%), 26-45 
min (A: 90%; B: 10%) and detected at the wavelength 
of 205nm. Re-equilibration duration was 15 minutes 
between individual runs
 
[40]. 
HPLC analysis for qualification of quercetin 
was carried out by gradient elution beginning with a 
mobile phase A (acetonitrile) and B (0.2% of acetic 
acid) at the flow rate of 0.5 ml/min. The elution 
concentration of mobile phase were: 0-12 min (A: 
30%; B: 70%), 12-13 min (A: 33%; B: 67%), 13-31 min 
(A: 48%; B: 52%), 31-35 min (A: 63%; B: 37%), 35-80 
min (A: 100%; B: 0%) and detected at the wavelength 
of 205nm
 
[41]. Re-equilibration duration was 15 
minutes between individual runs. 
The chromatographic peaks from EEZJ were 
identified by comparing the retention time to the 
reference standard compounds which underwent the 
same condition of elution. Each sample and reference 
standard were analysed for three times for the 
precision of the analysis. 
Data obtained were analysed statistically 
using GraphPad PRISM. All data are presented as 
means a ± standard error of the mean (S.E.M). Data 
were evaluated by one-way analysis of variance 
(ANOVA) followed by Dunnett’s post hoc test. The 
level of statistical significance was set at P ≤ 0.001 
(***) or P ≤ 0.01 (**) or P ≤ 0.05 (*) when compared to 
control group. 
 
 
Result  
 
The yield of a crude ethanolic extract of Z. 
jujuba was 1620.68 g, from 2744.58 g. The yield 
percentage was 59.05%. 90% of the extract was 
subjected to in vivo test while another 10% was 
subjected to qualification analysis. 
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Two parameters were employed in this test, 
which is the number of colonies growing in the petri 
dish and the ulcer index. Positive control greatly 
reduces the number of colonies growing on petri dish; 
nevertheless, the results were not sufficient to be 
statistically significant. Test groups postulate a 
decreasing trend in reducing the number of colonies in 
a dose depending manner. However, the results are 
not statistically significant.  
However, Table 1 shows that the EEZJ 
inhibited the growth of bacteria in vivo in a dose 
depending manner, although there were no ulcers 
observed in our experiment. Orally administered E. 
coli demonstrated some redness like inflammation 
and ulcerative presentation at the intestinal tissue 
during post-mortem session. 
Table 1: Antibacterial activity 
Compound Dosage (mg/kg) Number of Colonies Ulcer Index 
Control - 162.83 ± 49.57 0.82 ± 0.02 
Amoxicillin 260 60.67 ± 18.11
 ns
 0.80 ± 0.00 
ns
 
EEZJ 400 140.83 ± 48.14 
ns
 0.82 ± 0.04 
ns
 
EEZJ 800 122.83 ± 52.64 
ns
 0.77 ± 0.05 
ns
 
EEZJ 1200 117.00 ± 38.26 
ns
 0.88 ± 0.02 
ns
 
(means ± S.E.M; n = 6); ns P ≥ 0.05 compared to control (One-way ANOVA followed by 
Dunnett’s Test); *P ≤ 0.05 compared to control (One-way ANOVA followed by Dunnett’s 
Test)’ **P ≤ 0.01 compared to control (One-way ANOVA followed by Dunnett’s Test). 
 
Based on Table 2, the extractions produced 
no significant results in parameters such as the 
proportion of watery stools, and the onset of diarrhoea 
when compared statistically to the control group. 
However, there is a trend of reducing the proportion of 
the weight of watery stool in mice treated with different 
concentration of EEZJ. Not only that, but mice treated 
with EEZJ also delayed the onset of diarrhoea 
compared to control group. However, the results 
obtained were not statistically significant. Among three 
concentrations of EEZJ, only EEZJ 1200 mg/kg 
produced a significant result (P ≤ 0.01) in reducing a 
number of watery stools. This significant level was 
comparable with positive control as it also produced a 
significant result (P ≤ 0.01). Furthermore, EEZJ 1200 
mg/kg was the only test group that produced a 
significant result (P ≤ 0.05) when compared to control 
group in reducing a total number of the stool. From 
Table 3, it shows increasing inhibition of both 
defaecation and diarrhoea frequency with increasing 
concentration of EEZJ. Positive control produced the 
similar significance level when compared to negative 
control (P ≤ 0.05) regarding reducing a total number of 
stool. Loperamide was the only group that showed the 
significant result in all parameters when compared to 
control group. 
Table 2: Preliminary antidiarrhoeal test  
Compound Dosage 
(mg/kg) 
The proportion of 
Weight of Watery 
Stool (%) 
The onset of 
Diarrhoea (hour) 
Total Number of 
Defecation 
Number of Watery 
Stool 
Control - 92.73 ± 6.70 1.00 ± 0.00 12.67 ± 1.20 11.67 ± 1.76 
EEZJ 100 96.19 ± 3.62 ns 1.33 ± 0.33 ns 12.67 ± 1.76 ns 11.67 ± 2.33 ns 
EEZJ 400 75.47 ± 8.81 ns 2.67 ± 0.33** 13.67 ± 1.76 ns 9.00 ± 1.00 ns 
(means ± S.E.M; n = 3); ns P ≥ 0.05 compared to control (One-way ANOVA followed by 
Dunnett’s Test); *P ≤ 0.05 compared to control (One-way ANOVA followed by Dunnett’s 
Test); **P ≤ 0.01 compared to control (One-way ANOVA followed by Dunnett’s Test). 
 
As shown in Table 4 and Table 5, anti-
inflammatory activity of Z. jujuba is significant when 
compared to negative control group (2% tragacanth) 
all the time. The experimental findings from the 
carrageenan-induced rat paw oedema model showed 
that the Z. jujuba ethanolic extract reduced the paw 
volume significantly (P≤0.001) from 1 h to 6 h. 
Inhibition of paw oedema formation was shown in 
three doses of Z. jujuba ethanolic extract. However, 
the anti-inflammatory effect exerted by Z. jujuba 
ethanolic extract was less potent than that found with 
positive control drugs. Furthermore, the onset of anti-
inflammatory action of Z. jujuba ethanolic extract was 
found to be comparable with that of control positive 
drug. 
Table 3: In vivo antidiarrhoeal activity  
Compound Dosage 
(mg/kg) 
The 
proportion 
of Weight 
of Watery 
Stool (%) 
The onset of 
Diarrhoea 
(hour) 
Total 
Number of 
Stools 
Number 
of Watery 
Stool 
Inhibition of 
Defecation 
(%) 
Inhibition of 
Diarrhoea 
(%) 
Control - 83.07 ± 
5.98 
1.83 ± 0.31 16.33 ± 
1.50 
13.17 ± 
2.06 
0.0 0.0 
Loperamide 4.2 42.49 ± 
14.57* 
3.67 ± 0.56* 6.83 ± 
2.75* 
3.83 ± 
1.72** 
58.16 70.89 
EEZJ 400 77.34 ± 
3.70 ns 
2.33 ± 0.21 ns 11.17 ± 
1.90 ns 
9.00 ± 
0.97 ns 
31.63 31.66 
EEZJ 800 73.00 ± 
3.90 ns 
2.33 ± 0.33 ns 10.50 ± 
1.38 ns 
8.67 ± 
1.01 ns 
35.70 34.17 
EEZJ 1200 66.23 ± 
12.06 ns 
2.83 ± 0.48 ns 8.50 ± 
1.82* 
4.33 ± 
1.45** 
47.95 67.09 
(means ± S.E.M; n = 6); ns P ≥ 0.05 compared to control (One-way ANOVA followed by 
Dunnett’s Test); *P ≤ 0.05 compared to control (One-way ANOVA followed by Dunnett’s 
Test); **P ≤ 0.01 compared to control (One-way ANOVA followed by Dunnett’s Test. 
 
According to Table 4 and 5, both three doses 
of Z. jujuba ethanolic extract successfully controlled 
the percentage of paw oedema under 40%. 1200 
mg/kg Z. jujuba ethanolic extract treatment group has 
a higher percentage of paw oedema inhibition when 
compared to that of 800 mg/kg and 1600 mg/kg Z. 
jujuba ethanolic extract treatment groups. 800 mg/kg 
Z. jujuba ethanolic extract treatment group has 
weakest anti-inflammatory effect at the corresponding 
time point.  
Table 4: Percentage of right paw oedema (%) calculated from 
the change in paw volume after treatment 
Group Treatment Dose 
(mg/kg) 
Percentage of right paw oedema (%) after treatment 
(Mean + SEM) 
   1 h 2 h 3 h 4 h 5 h 6 h 
1 EEZJ 800 7.60 + 
1.12*** 
14.00 + 
1.58*** 
20.80 + 
1.72*** 
25.40 + 
1.69*** 
30.20 + 
2.08*** 
36.00 + 
2.68*** 
2 EEZJ 1200 8.00 + 
1.27*** 
13.40 + 
1.20*** 
18.40 + 
1.50*** 
24.00 + 
1.79*** 
30.00 + 
2.43*** 
32.80 + 
3.41*** 
3 EEZJ 1600 6.00 + 
0.45*** 
16.00 + 
1.76*** 
21.40 + 
1.33*** 
26.80 + 
1.78*** 
30.40 + 
1.86*** 
35.00 + 
2.24*** 
4 Diclofenac 
Sodium 
100 3.20 + 
1.07*** 
8.00 + 
1.30*** 
13.60 + 
2.34*** 
18.00 + 
2.67*** 
21.20 + 
2.56*** 
23.20 + 
2.35*** 
5. Control 100 28.00 + 
4.72 
45.80 + 
5.00 
68.00 + 
5.06 
89.20 + 
6.59 
105.20 + 
10.10 
114.00 + 
10.07 
(means ± S.E.M; n = 5); ns P ≥ 0.05 compared to control (One-way ANOVA followed by 
Dunnett’s Test); * P ≤ 0.05 compared to control (One-way ANOVA followed by Dunnett’s 
Test); ** P ≤ 0.01 compared to control (One-way ANOVA followed by Dunnett’s Test); *** P 
≤ 0.001 compared to control (One-way ANOVA followed by Dunnett’s Test). 
 
 
Apart from that, all three doses of Z. jujuba 
ethanolic extract showed a similar trend of oedema 
development. Additionally, the Z. jujuba ethanolic 
extract produced the dose-dependent significant anti-
inflammatory activity as the lowest dose, 800 mg/kg 
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showed least anti-inflammatory activity when 
compared to other two with the higher dose. 
 
According to Table 6 and 7, the three doses 
of Z. jujuba ethanolic extract successfully controlled 
the thickness of paw that due to oedema when 
compared with that of the negative control group. The 
1200 mg/kg Z. jujuba ethanolic extract treatment 
group has a higher percentage of paw oedema 
inhibition when compared to the 800 mg/kg and 1600 
mg/kg Z. jujuba ethanolic extract treatment groups. 
However, all the three doses of Z. jujuba ethanolic 
extract exhibited lower anti-inflammatory activity than 
the positive control group. 
Table 5: Percentage of left paw oedema (%) calculated from the 
change in paw volume after treatment 
Group Treatment Dose 
(mg/kg) 
Percentage of left paw oedema (%) after treatment (Mean 
+ SEM) 
   1 h 2 h 3 h 4 h 5 h 6 h 
1 EEZJ 800 6.80 + 
1.16*** 
13.40 + 
2.54*** 
19.80 + 
3.09*** 
25.80 + 
3.80*** 
31.00 + 
4.38*** 
37.00 + 
4.45*** 
2 EEZJ 1200 6.00 + 
0.63*** 
12.60 + 
1.75*** 
17.40 + 
2.11*** 
24.40 + 
4.13*** 
29.40 + 
4.68*** 
32.20 + 
4.12*** 
3 EEZJ 1600 5.80 + 
0.37*** 
12.80 + 
1.36*** 
17.40 + 
1.17*** 
25.00 + 
1.82*** 
29.00 + 
1.92*** 
34.20 + 
2.48*** 
4 Diclofenac 
Sodium 
100 2.20 + 
0.37*** 
6.40 + 
0.81*** 
10.20 + 
2.60*** 
14.00 + 
2.59*** 
17.60 + 
2.46*** 
19.80 + 
2.29*** 
5. Control 100 23.60 + 
4.78 
41.80 + 
4.60 
60.00 + 
4.37 
78.00 + 
6.72 
93.20 + 
6.58 
102.60 + 
6.81 
Means ± S.E.M; n = 5); ns P ≥ 0.05 compared to control (One-way ANOVA followed by 
Dunnett’s Test); *P ≤ 0.05 compared to control (One-way ANOVA followed by Dunnett’s 
Test); **P ≤ 0.01 compared to control (One-way ANOVA followed by Dunnett’s Test); *** P 
≤ 0.001 compared to control (One-way ANOVA followed by Dunnett’s Test). 
 
 
The HPLC chromatograms of the reference 
standards and EEZJ are shown in the Fig. 1A, 1B, 1C 
and 1D, respectively. UV absorption, retention time 
and identification results of peaks are presented in 
Table 8. 
Table 6: Percentage of right paw oedema (%) calculated from 
the change in paw thickness after treatment 
Group Treatment Dose 
(mg/kg) 
Percentage of right paw oedema (%) after treatment 
(Mean + SEM) 
   1 h 2 h 3 h 4 h 5 h 6 h 
1 EEZJ 800 14.00 + 
4.93
ns 
19.33 + 
4.41
ns
 
21.67 + 
3.38** 
25.33 + 
2.91* 
20.33 + 
9.33** 
26.67 + 
7.13** 
2 EEZJ 1200 6.33 + 
1.45* 
14.33 + 
2.33* 
20.67 + 
1.76** 
22.67 + 
3.48** 
23.00 + 
5.20* 
21.00 + 
6.81*** 
3 EEZJ 1600 10.33 + 
0.88
 ns
 
20.00 + 
1.53
 ns
 
25.33 + 
0.88* 
24.67 + 
6.57* 
26.33 + 
5.78* 
24.67 + 
1.20** 
4 Diclofenac 
Sodium 
100 3.00 + 
0.58** 
8.00 + 
1.00** 
10.00 + 
1.53*** 
8.66 + 
3.28*** 
10.00 + 
4.50** 
13.33 + 
3.18*** 
5. Control 100 19.33 + 
3.53 
31.00 + 
4.73 
39.00 + 
4.36 
46.00 + 
2.52 
56.00 + 
4.51 
62.33 + 
3.71 
Means ± S.E.M; n = 5); ns P ≥ 0.05 compared to control (One-way ANOVA followed by 
Dunnett’s Test); *P ≤ 0.05 compared to control (One-way ANOVA followed by Dunnett’s 
Test); **P ≤ 0.01 compared to control (One-way ANOVA followed by Dunnett’s Test); *** P 
≤ 0.001 compared to control (One-way ANOVA followed by Dunnett’s Test). 
 
Peak 1 represented the present of betulinic 
acid at the retention time of 42.169 minutes from 
reference compound. EEZJ showed a peak at the 
same retention time. Hence, EEZJ consists of 
betulinic acid as the peak was comparable to 
reference compound (Fig. 1).  
Peak 2 appeared at 16.821 minutes in the 
reference compound and represented as quercetin. 
EEZJ showed a peak at the same retention time 
which indicates the presence of quercetin in the 
extract tested (Fig. 1).  
 
Discussion 
 
People in different communities commonly 
use plant or plant derivatives to cure illnesses without 
scientific evidence. The current studies aimed to 
evaluate anti-diarrhoeal as well as anti-inflammatory 
activity potential of Z. jujuba fruit. Castor oil was given 
to mice to imitate the diarrhoea symptom while 
carrageenan was given to rats to induce inflammation 
at the paw of the rats.  
Table 7: Percentage of left paw oedema (%) calculated from the 
change in paw thickness after treatment 
Group Treatment Dose 
(mg/kg) 
Percentage of left paw oedema (%) after treatment 
(Mean+SEM) 
   1 h 2 h 3 h 4 h 5 h 6 h 
1 EEZJ 800 12.67 + 
3.18** 
22.00 + 
7.55
 ns
 
28.67 + 
6.33
 ns
 
27.33 + 
5.55** 
30.33 + 
6.94** 
30.67 + 
4.41*** 
2 EEZJ 1200 7.00 + 
0.58*** 
15.00 + 
1.53* 
19.33 + 
0.88** 
19.00 + 
1.16*** 
22.67 + 
1.67*** 
19.67 + 
1.76*** 
3 EEZJ 1600 10.33 + 
0.33** 
19.67 + 
2.73
 ns
 
25.00 + 
3.00* 
31.33 + 
1.20* 
28.00 + 
4.36** 
27.33 + 
3.53*** 
4 Diclofenac 
Sodium 
100 3.00 + 
0.58*** 
6.00 + 
1.00** 
8.33 + 
0.67*** 
8.33 + 
1.33*** 
6.33 + 
1.33*** 
12.00 + 
7.69*** 
5. Control 100 22.33 + 
2.03 
31.33 + 
1.67 
40.33 + 
2.33 
46.67 + 
2.67 
53.33 + 
1.20 
56.00 + 
2.08 
Means ± S.E.M; n = 5); ns P ≥ 0.05 compared to control (One-way ANOVA followed by 
Dunnett’s Test); * P ≤ 0.05 compared to control (One-way ANOVA followed by Dunnett’s 
Test); ** P ≤ 0.01 compared to control (One-way ANOVA followed by Dunnett’s Test); *** P 
≤ 0.001 compared to control (One-way ANOVA followed by Dunnett’s Test) 
 
The minimum effective dose of EEZJ that 
determined in the preliminary test was brought into the 
experimental test. Moreover, two higher concentration 
of EEZJ (800 mg/kg and 1200 mg/kg) were added into 
the test to evaluate the effectiveness in gradual 
increasing dose.  
Table 8: Method employed, retention time, and ultraviolet 
absorption of betulinic acid, quercetin and ethanolic extract of 
Ziziphus jujuba 
Compound Method Constituent Retention Time 
(min) 
UV Absorption 
(nm) 
Standard 1 Zhang et al. 2008 Betulinic Acid 42.169 205 
EEZJ Zhang et al. 2008 Betulinic Acid 42.169 205 
Standard 2 Guo et al. 2011 Quercetin 16.821 205 
EEZJ Guo et al. 2011 Quercetin 16.821 205 
 
Loperamide (loperamide hydrochloride) 
served as a positive control group in the experiment 
as it acts directly at the opioid receptors on the 
circular and longitudinal intestinal mucosa. Similar to 
other µ-receptor agonists, loperamide inhibits 
peristalsis of the intestine and prolongs the transit 
time of the digested content. Loperamide also 
stimulates the reabsorption process and alters the 
transport of water and electrolytes. Thus, it reduces 
the faecal volume and decreases the fluid and 
electrolyte loss. Loperamide not only used in acute 
diarrhoea patient but also successfully applied in 
chronic diarrhoea patient for several years without 
evidence of tolerance
 
[42].  
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Based on the results obtained and presented 
in Table 3, mice treated with different concentrations 
of EEZJ produced a reduced number of watery 
dropping as well as a total number of faeces. 
 
A
 
B
 
C
 
D
 
Figure 1: A) Chromatographic profile of standard; 1 = Betulinic acid; B) 
Chromatographic profile of standard; 2 = Quercetin; C) Chromatographic 
profile of ethanolic extract of Ziziphus jujube; 1 = Betulinic acid; D) 
Chromatographic profile of ethanolic extract of Ziziphus jujube; 2 = Quercetin 
 
This result is similar to the studies done by Oh 
and Ryu
 
[43], where they proposed that Korean 
oriental medicine which containing Z. jujuba fruit, can 
reduce the number of faeces of mice in five hours of 
observation. A similar observation was reported by Hu 
et al.
 
[44]
 
where a Chinese traditional medicine (Wei-
Chang-An-Wan extract) containing Z. jujuba fruit was 
able to reduce the total number of faeces significantly 
and the number of watery dropping.  
Stool weight depends on many factors such 
as water composition, number of bacteria and fibre 
content in the stool. In addition to this, total stool 
weight is highly correlated with the frequency of 
defaecation
 
[45]. In our experiment, EEZJ did not only 
reduce the number of stool but also induced mice to 
produce a lesser weight of watery stool. Muller et al. 
[46] in their work concluded that the gastrointestinal 
transit time would affect the weight of stool where 
longer gastrointestinal transit time will produce lighter 
stool weight. Which was also tested by Rao and 
Lakshimi [44], where they also displayed the aqueous 
extract of Z. jujuba leaves to increase the 
gastrointestinal transit time. Hence, it may indicate 
that Z. jujuba fruit in our experiment may reduce stool 
weight by increasing the gastrointestinal transit time. 
EEZJ did not only reduce stool weight and 
some faeces, but it also delayed the onset of first 
watery dropping compared to control group. Z. jujuba 
can reduce the intestinal motility, and this has been 
described by Rao and Lakshimi
 
[47]. Hu et al. [44] 
demonstrated that Z. jujuba containing traditional 
medicine able to attenuate the gastrointestinal tract 
motility in a dose depending manner. Based on the 
same studies, Z. jujuba containing traditional medicine 
also decreased the spontaneous contraction of 
isolated jejunum in animals. In our study, the result 
showed that EEZJ could reduce the number of faeces 
as well as the weight of faeces in a dose depending 
manner. Moreover, it significantly attenuated the onset 
of first watery dropping from the mice. With these 
characteristics, EEZJ can be considered as 
possessing antidiarrhoeal activity against castor oil-
induced diarrhoea. 
Inflammation process causes an alteration in 
human body’s physiological responses and ultimately 
resulting in pain, heat, redness, swelling and loss of 
function. Carrageenan-induced paw oedema is an 
example of acute inflammation which results in 
swelling. It had been widely used as an experimental 
animal model to discover and evaluation of anti-
inflammatory potential
 
[48].  
Carrageenan is a complex group of 
polysaccharides made up of repeating galactose-
related monomers. The inflammatory response is 
usually quantified by an increase in paw size which is 
observed for around five hours after carrageenan 
injection
 
[32]. Inhibition of carrageenan-induced 
inflammation has been shown to be highly predictive 
of anti-inflammatory activity in human inflammatory 
disease and doses of nonsteroidal anti-inflammatory 
drugs (NSAIDs) in this model correlate well with 
effective dose in patients
 
[49]. Using antagonists of 
various mediators of inflammation showed that the 
inflammatory response to carrageenan consisted of 
three phases
 
[50]. The primary phase is mediated by 
both histamine and 5-hydroxytryptamine. The second 
phase starts after one hour and persists for six hours 
after carrageenan injection. This phase is kinin-
mediated.  
The final phase is attributed to the local 
production of prostaglandins, which is derived from 
arachidonic acid by the action of cyclooxygenase 
(COX) enzymes. Inhibition of these enzymes is the 
basis of action of the NSAIDs of major clinical 
importance in the treatment of pain and inflammation
 
[51]. Cyclooxygenase 2 (COX-2) is a pro-inflammatory 
enzyme which is in charge of making prostaglandins 
(PG), and it is also the site of action targeted by non-
steroidal anti-inflammatory drugs such as diclofenac 
and COX-2 inhibitors. However, COX-2 is normally 
produced within the second hour after carrageenan is 
induced to cause inflammation. This means PG is not 
involved in oedema formation in the very first hour but 
instead contribute to oedema within second and the 
subsequent hours.  
According to Di Lorenzo et al. [52], 
carrageenan injection evokes neutrophil infiltration 
immediately after injection and persists for six hours. 
O2
-
, OH and H2O2 which are derived from neutrophils, 
are suggested to cause a sustained increase in 
permeability through damaging the endothelial cells
 
[53]. Thus, carrageenan-induced paw oedema has 
been an important tool in the development of NSAIDs. 
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A role for neutrophil-derived reactive oxygen species, 
nitric oxide, and peroxynitrite in carrageenan-induced 
inflammation has also been identified, and some 
specific inhibitors have been identified which have 
potential clinical use. 
Diclofenac sodium is superior to the other 
clinically established non-steroidal anti-inflammatory 
agents in carrageenan-induced paw oedema
 
[54]. It 
exerts their effect by blocking prostaglandin 
synthetase system. In the present study, diclofenac 
sodium significantly expressed its anti-inflammatory 
activity in Table 4-7. The result of the present study 
showed and solidified that diclofenac sodium has 
significant anti-inflammatory activity. 
According to the anti-inflammatory 
experiments that were carried out, Z. jujuba ethanolic 
extract successfully controlled the inflammation of the 
paw. At 1200 mg/kg dose of Z. jujuba ethanolic extract 
displayed the highest paw oedema inhibition. The 
mechanisms of action of Z. jujuba ethanolic extract 
may be similar to that diclofenac sodium whereby the 
anti-inflammatory effect observed might be due to the 
inhibition of expression and activity of COX-2. 
Based on the chemical analysis done, it was 
found that Z. jujuba fruit contains both betulinic acid 
and quercetin in it. Earlier studies showed that most of 
the medical plants could counter dysentery and 
diarrhoeal incident. Most of the medical plants contain 
alkaloids, saponins, flavonoids, sterols and 
triterpenoid
 
[55] and they are responsible for the 
mechanism of antidiarrhoeal activity. Betulinic acid 
belongs to the pentacyclic triterpenoid group [56], 
whereas quercetin belongs to flavonoids group
 
[13]. 
From the earlier statement, we understand that both 
triterpenoid and flavonoids capable of possessing 
antidiarrhoeal activity. This is further support by 
Ezekwesili et al.
 
[57] studies, where he described that 
quercetin relaxes the intestinal smooth muscle and 
inhibits bowel contraction which probably due to 
inhibition of intracellular release of calcium ions from 
the sarcoplasmic reticulum. Other than that, Begum et 
al.
 
[58] claimed that triterpenoid also had been shown 
to possess antispasmodic activity in a dose depending 
manner.  
From previous studies, betulinic acid is 
considered to have a potent anti-inflammatory activity 
where betulinic acid can reduce the production of 
TNF-α as well as nitric oxide in mice. Additionally, 
betulinic acid also found to promote the concentration 
of IL-10 upon LPS stimulation
 
[59][60], and quercetin 
was able to regulate down the inflammatory response 
of in vitro bone marrow-derived macrophages. They 
further proof that quercetin to inhibit the release of 
cytokine and induce the nitric oxide synthase via 
inhibition of NF-κB pathway without modification of c-
Jun N-terminal kinase activity. 
Besides that, different kinds of methods were 
tried during the chemical analysis for better resolution 
and separation of target peak. All of it was run at the 
maximum wavelength of 205 nm as the study 
compound from Z. jujuba has wavelength maximum at 
205 nm. According to Guo et al.
 
[33], suggested 
acetonitrile to be used as a mobile phase because 
acetonitrile has low wavelength maximum compared 
to methanol where acetonitrile avoids blank 
interference during the analysis. Therefore, low peaks 
of EEZJ can be observed due to less blank 
interference. Guo et al. group reported the mobile 
phase with a buffered acid to produce a better 
separation of peaks. This is particularly in case of 
betulinic acid analysis as buffer acid improved the 
peak shape and eliminated the tailing of the target 
peak
 
[61].  
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